Clinical trials for Cancer in United States

Study to Investigate Lifileucel Regimen Plus Pembrolizumab Compared With Pembrolizumab Alone in Participants With Untreated Advanced Melanoma.

Study ID: NCT05727904

Sponsor

Iovance Biotherapeutics, Inc.

A Study of Avutometinib, Defactinib, and Letrozole in People With Low-Grade Serous Ovarian Cancer

Study ID: NCT06394804

Sponsor

Memorial Sloan Kettering Cancer Center

Cancer Experience Registry (CER) for Cancer Patients and Caregivers

Study ID: NCT02333604

Sponsor

Cancer Support Community, Research and Training Institute, Philadelphia

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7502175 as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

Study ID: NCT05581004

Sponsor

Genentech, Inc.

Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis

Study ID: NCT05201404

Sponsor

Can-Fite BioPharma

ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services

Study ID: NCT06128304

Sponsor

University of California, San Diego

Glofitamab With Obinutuzumab Pre-treatment for the Treatment of Central Nervous System Lymphoma

Study ID: NCT06922604

Sponsor

City of Hope Medical Center

A Study of Ivaltinostat Plus Capecitabine or Capecitabine in Metastatic Pancreatic Adenocarcinoma

Study ID: NCT05249101

Sponsor

CG Pharmaceuticals, Inc

Longitudinal Evaluation of Microbial and Host Signatures During Immunotherapy for Lung Cancer

Study ID: NCT04063501

Sponsor

NYU Langone Health

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Preliminary Efficacy of Relatlimab Plus Nivolumab in Pediatric and Young Adults With Hodgkin and Non-Hodgkin Lymphoma

Study ID: NCT05255601

Sponsor

Bristol-Myers Squibb